… the use of convalescent plasma in the battle against this new strain of coronavirus, it is …
Accordingly, the aim of this review is to examine in detail studies of convalescent plasma used …

… a target and a potential therapeutic against SARS coronavirus 2 (SARS-CoV-2; the causative
… We suggested that this drug could be of use in countering SARS-CoV-2 infections, subject …

… convalescent plasma therapy for COVID-19 in children. We found insufficient clinical
information on the safety and efficacy of convalescent plasma … that convalescent plasma therapy …

… of convalescent plasma (CP) with higher anti-SARS-CoV-2 IgG … received a transfusion of
convalescent plasma with lower … , patients treated with convalescent plasma vs. conventional …

… with 300mL convalescent plasma containing high titers of neutralizing SARS-CoV-2 …
Convalescent plasma is safe, does not improve survival, has no effect on the disease course…

… Although we tested only one plasma sample from an individual infected with a SARS-CoV-2 …
a, We obtained convalescent plasma and sequenced the matching infecting virus from …

… was primarily collected from individuals for whom SARS-CoV-2 infection had … 256 convalescent
plasma donors were identified as having had a previous laboratory-confirmed SARS-CoV…

… Characterisation of the human antibody response to SARS-CoV-2 infection is vital for … with
convalescent plasma or immunoglobulin products derived from convalescent plasma. In this …

… coronavirus 2 (SARS-CoV-2) isolates identified viral variants that are less susceptible …
neutralization by convalescent plasma (CP), vaccine-elicited plasma/sera, or SARS- CoV-2 …

… convalescent plasma studies did not assess neutralizing activity in convalescent plasma
but … any of the antibody types among the 12 SARS-CoV-2 reactivities detected by ABCORA …